SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on July 3, 2024, for the potential sale of up to 650,447 shares of common stock. These shares are associated with Series A and Series B common warrants previously issued to a single institutional investor, Armistice Capital, LLC, in a private placement. The warrants, exercisable at $20.75 per share, were part of a securities purchase agreement dated January 26, 2024. SeaStar Medical will not receive proceeds from the sale of shares by the Selling Securityholder but will receive the exercise price if the warrants are not exercised on a cashless basis. The registration allows the Selling Securityholder to resell the shares from time to time, with...Show More

SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on July 3, 2024, for the potential sale of up to 650,447 shares of common stock. These shares are associated with Series A and Series B common warrants previously issued to a single institutional investor, Armistice Capital, LLC, in a private placement. The warrants, exercisable at $20.75 per share, were part of a securities purchase agreement dated January 26, 2024. SeaStar Medical will not receive proceeds from the sale of shares by the Selling Securityholder but will receive the exercise price if the warrants are not exercised on a cashless basis. The registration allows the Selling Securityholder to resell the shares from time to time, with SeaStar Medical bearing all registration expenses. The Selling Securityholder may sell the shares through various methods, including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and the company's financial statements audited by WithumSmith+Brown, PC, and Armanino LLP.